LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/FDA Digs Up 600,000 Hidden Adverse Event Reports
Legal & Regulatory and Reimbursement

FDA Digs Up 600,000 Hidden Adverse Event Reports

June 25, 2019 2 min read Premium comments

Advertisement

FDA Digs Up 600,000 Hidden Adverse Event Reports
FDA Digs Up Hidden Adverse Event Data / Source: Wikimedia Commons, Howard Pyle and RRY Publications
Secondary

On Friday, June 21, 2019, Jeff Shuren, M.D., director of the FDA’s Center for Devices and Radiological Health (CDRH), made good on former FDA Commissioner Scott Gottlieb, M.D.’s promise to release more than 20 years of non-public reports of adverse events involving medical devices.

The agency thus ended the Alternative Summary Reporting (ASR) Program and revoked all such exemptions. The FDA is now making over 600,000 reports received under ASR exemptions from 1999 to 2019 available in the data files linked here.

The files contain ASR data by reporting year, comprising over six million records in total over the last 20-plus years. Each file is large and contains all ASRs received for that year. These are compressed data files using the zip format. After files are downloaded, they should be unzipped.

The FDA makes medical device reports available to the public on the FDA’s public MAUDE database. However, the agency said there were certain cases where reports were not included in MAUDE. Older reports received through CDRH’s legacy Device Experience Network (DEN) reporting system from 1984 – 1996 and reports received under the Alternative Summary Reporting Program from 1999 – April 2019 were not available in MAUDE. Those reports are now available.

In a written statement, Shuren said the FDA also has informed 13 manufacturers that they’ve lost ASR exemptions for devices.

He added that the agency has been working on sunsetting the ASR program since 2017 as it developed the recently unveiled Voluntary Malfunction Summary Reporting Program. That program allows device makers to report events in a quarterly summary that’s made publicly available through MAUDE.

Kaiser Health Network Exposé

As we reported in April, “Gottlieb Promises to Open Hidden Device Database,” this all came to light after the Kaiser Health Network (KHN) began filing Freedom of Information Act (FOIA) requests for the “alternative summary reporting” database and for other special “exemption” reports. But the agency denied a request for expedited delivery of those records, saying the lack of “compelling need” for the public to have the information. Officials noted that it might take up to two years to get such records through the FOIA process.

Advertisement

KHN then went public on March 8, 2019 with a report titled, “Hidden FDA Reports Detail Harm Caused By Scores Of Medical Devices.”

Three weeks later, then-Commissioner Gottlieb wrote:

“This is an old database where historical information wasn’t easily accessible electronically owing to the system’s age. But it’s imperative that all safety information be available to the public. We’re now prioritizing making ALL of this data available.”

The agency has now made good on that promise.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy